Cargando…
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
mRNA expression of the DLC1 tumor suppressor gene is downregulated in many lung cancers and their derived cell lines, with DLC1 protein levels being low or absent. Although the role of increased EZH2 methyltransferase in cancer is usually attributed to its histone methylation, we unexpectedly observ...
Autores principales: | Tripathi, Brajendra K., Anderman, Meghan F., Bhargava, Disha, Boccuzzi, Luciarita, Qian, Xiaolan, Wang, Dunrui, Durkin, Marian E., Papageorge, Alex G., de Miguel, Fernando J., Politi, Katerina, Walters, Kylie J., Doroshow, James H., Lowy, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642553/ https://www.ncbi.nlm.nih.gov/pubmed/34862367 http://dx.doi.org/10.1038/s41467-021-26993-3 |
Ejemplares similares
-
SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions
por: Tripathi, Brajendra K., et al.
Publicado: (2019) -
CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014) -
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016) -
DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017) -
Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2017)